Novartis Partners with Alibaba Health to Enhance Patient Medication Accessibility
The 5th China International Import Expo (CIIE) saw the announcement of a partnership between Swiss...
RemeGen’s Telitacicept Set for Breakthrough Therapy Designation in Myasthenia Gravis
The Center for Drug Evaluation (CDE) website indicates that China-based RemeGen Co., Ltd’s (HKG: 9995,...
Harbour BioMed and Moderna Ink Licensing Deal for Oncology Immunotherapies
Harbour BioMed (HKG: 2142), a biotech company with operations in the United States, the Netherlands,...
CStone’s PD-L1 Inhibitor Sugemalimab Achieves Primary Endpoint in Gastric Cancer Study
China-based CStone Pharmaceuticals (HKG: 2616) has announced that its GEMSTONE-303 study for the programmed death-ligand...
BeiGene’s Brukinsa Receives Marketing Approval in Brazil
China-based biotech BeiGene Inc. (HKG: 6160, SHA: 688235, NASDAQ: BGNE) has announced that it has...
Fujian Cosunter Receives Multiple Patents for Cancer and Hepatitis Drugs
China-based Fujian Cosunter Pharmaceutical Co., Ltd (SHE: 300436) has announced the receipt of multiple patents...
Sinocelltech’s SCTV01E Vaccine Receives NMPA Approval for Phase II Study
China-based Sinocelltech Group Ltd (SHA: 688520) has announced that it has received approval from the...
3SBio’s Thrombopoietin Study in Pediatric ITP Reaches Primary Endpoint
China-based 3SBio Inc. (HKG: 1530) has announced that its multi-center, randomized, double-blind, placebo-controlled study assessing...
Zenas BioPharma Completes $118M Series B Financing to Advance Obexelimab
Autoimmune disease drug developer Zenas BioPharma, which is based in the US and China, has...
LianBio Initiates Phase I Study of SHP2 Inhibitor BBP-398 in China
Sino-US biotech LianBio has announced the first patient dosing in a Phase I clinical study...
Innovex Medical Files for IPO in Hong Kong to Boost Product Development
Innovex Medical Co., Ltd, a non-vascular interventional surgery solutions provider based in Shanghai, has filed...
Ascentage Pharma Gains CDE Approval for Phase I Study of APG-5918
Suzhou-based Ascentage Pharma (HKG: 6855) has announced that it has received approval from the Center...
China Releases 14th Five-Year Plan for National Health Informatization
The National Health Commission (NHC), National Administration of Traditional Chinese Medicine, and the National Bureau...
Zai Lab Reports 33% YOY Revenue Growth in Q3 2022
Chinese biopharmaceutical firm Zai Lab Ltd (NASDAQ: ZLAB, HKG: 9688) released its Q3 2022 earnings...
GSK Partners with CASPC to Advance HIV Sustained Care Advocacy in China
The 5th China International Import Expo (CIIE) saw the unveiling of a partnership between GlaxoSmithKline...
3SBio Receives NMPA Review for Pediatric ITP Thrombopoietin Filing
China-based 3SBio Inc. (HKG: 1530) has announced that the National Medical Products Administration (NMPA) has...
Boston Scientific Partners with Omron for Atrial Fibrillation Management
US-based Boston Scientific Corporation (NYSE: BSX) has announced a partnership with Japan-based Omron Healthcare at...
Takeda Partners with AWS and Accenture to Launch Innovation Incubator at CIIE
The 5th China International Import Expo (CIIE) saw the announcement of a partnership between Takeda...
Betta Pharmaceuticals’ BPI-D0316 Shows Promise in Phase II/III Lung Cancer Study
China-based Betta Pharmaceuticals Co., Ltd (SHE: 300558) has announced the summary report of a Phase...